2025
SJR Q1
JCR Q2 · 3,8
OA
32 matched articles
SCIE
Journal detail
Journal of Microbiology, Immunology and Infection
- Publisher
- Elsevier Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
1684118219959133
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,066
- Quartile Q1
- H-Index 85
- Cites/doc 3,51
- Docs (3y) 426
- Cites (3y) 1.445
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,8
- 5Y JIF 3,5
- JCI 0,86
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Immunology and Allergy Q2
- Immunology and Microbiology (miscellaneous) Q1
- Infectious Diseases Q1
- Medicine (miscellaneous) Q1
- Microbiology (medical) Q2
Areas
- Immunology and Microbiology
- Medicine
WoS categories
- Immunology | Infectious Diseases | Microbiology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,066 | 3,8 | 3,5 | 0,86 | Q2 | 85 |
| 2024 | Q1 | Q2 | 1,009 | 3,7 | 3,7 | 0,98 | Q1 | 78 |
| 2023 | Q1 | Q1 | 1,04 | 4,5 | 4,1 | 1,27 | Q1 | 78 |
| 2022 | Q1 | Q1 | 1,45 | 7,4 | 5,3 | 1,48 | Q1 | 78 |
| 2021 | Q1 | Q1 | 1,748 | 10,3 | 5,8 | 1,38 | Q1 | 78 |
| 2020 | Q1 | Q2 | 1,223 | 4,4 | 3,4 | 0,83 | Q2 | 78 |
| 2019 | Q1 | Q2 | 0,947 | 3,5 | 2,7 | 0,72 | Q2 | 78 |
| 2018 | — | Q3 | — | 2,5 | 2,3 | 0,61 | Q3 | — |
| 2017 | Q2 | Q3 | 0,789 | 2,1 | 2 | 0,59 | Q3 | 78 |
| 2016 | Q1 | Q2 | 0,912 | 3 | 2,5 | — | — | 78 |
| 2015 | Q2 | Q2 | 0,842 | 3 | 2,4 | — | — | 78 |
| 2014 | Q1 | Q3 | 0,919 | 2,3 | 1,9 | — | — | 78 |
| 2013 | Q2 | Q3 | 0,815 | 2,1 | 1,8 | — | — | 78 |
| 2012 | Q2 | Q3 | 0,616 | 1,6 | — | — | — | 78 |
| 2011 | Q2 | Q4 | 0,545 | 1 | — | — | — | 78 |
| 2010 | Q2 | Q4 | 0,564 | 1,1 | — | — | — | 78 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q2 | Q2 | 81/183 |
| 2025 | INFECTIOUS DISEASES | SCIE | Q2 | Q2 | 41/141 |
| 2025 | MICROBIOLOGY | SCIE | Q2 | Q2 | 76/167 |
| 2024 | IMMUNOLOGY | SCIE | Q2 | Q2 | 75/183 |
| 2024 | INFECTIOUS DISEASES | SCIE | Q2 | Q1 | 35/137 |
| 2024 | MICROBIOLOGY | SCIE | Q2 | Q2 | 62/163 |
| 2023 | IMMUNOLOGY | SCIE | Q2 | Q1 | 61/181 |
| 2023 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 23/132 |
| 2023 | MICROBIOLOGY | SCIE | Q1 | Q1 | 40/161 |
| 2022 | IMMUNOLOGY | SCIE | Q1 | Q1 | 34/161 |
| 2022 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 16/96 |
| 2022 | MICROBIOLOGY | SCIE | Q1 | Q1 | 20/135 |
| 2021 | IMMUNOLOGY | SCIE | Q1 | Q1 | 27/162 |
| 2021 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 15/95 |
| 2021 | MICROBIOLOGY | SCIE | Q1 | Q1 | 17/137 |
| 2020 | IMMUNOLOGY | SCIE | Q2 | Q2 | 77/162 |
| 2020 | INFECTIOUS DISEASES | SCIE | Q2 | Q2 | 27/93 |
| 2020 | MICROBIOLOGY | SCIE | Q2 | Q2 | 46/136 |
| 2019 | IMMUNOLOGY | SCIE | Q2 | Q2 | 78/159 |
| 2019 | INFECTIOUS DISEASES | SCIE | Q2 | Q3 | 33/92 |
| 2019 | MICROBIOLOGY | SCIE | Q2 | Q2 | 48/136 |
| 2018 | IMMUNOLOGY | SCIE | Q3 | Q3 | 115/158 |
| 2018 | INFECTIOUS DISEASES | SCIE | Q3 | Q3 | 51/89 |
| 2018 | MICROBIOLOGY | SCIE | Q3 | Q3 | 84/133 |
| 2017 | IMMUNOLOGY | SCIE | Q4 | Q3 | 120/155 |
| 2017 | INFECTIOUS DISEASES | SCIE | Q3 | Q3 | 58/88 |
| 2017 | MICROBIOLOGY | SCIE | Q3 | Q3 | 82/126 |
| 2016 | IMMUNOLOGY | SCIE | Q3 | — | 78/151 |
| 2016 | INFECTIOUS DISEASES | SCIE | Q2 | — | 35/84 |
| 2016 | MICROBIOLOGY | SCIE | Q2 | — | 50/125 |
| 2015 | IMMUNOLOGY | SCIE | Q2 | — | 68/151 |
| 2015 | INFECTIOUS DISEASES | SCIE | Q2 | — | 27/83 |
| 2015 | MICROBIOLOGY | SCIE | Q2 | — | 46/123 |
| 2014 | IMMUNOLOGY | SCIE | Q3 | — | 95/148 |
| 2014 | INFECTIOUS DISEASES | SCIE | Q3 | — | 47/78 |
| 2014 | MICROBIOLOGY | SCIE | Q3 | — | 69/119 |
| 2013 | IMMUNOLOGY | SCIE | Q3 | — | 107/144 |
| 2013 | INFECTIOUS DISEASES | SCIE | Q3 | — | 50/72 |
| 2013 | MICROBIOLOGY | SCIE | Q3 | — | 72/119 |
| 2012 | IMMUNOLOGY | SCIE | Q4 | — | 114/137 |
| 2012 | INFECTIOUS DISEASES | SCIE | Q4 | — | 55/70 |
| 2012 | MICROBIOLOGY | SCIE | Q3 | — | 82/116 |
| 2011 | IMMUNOLOGY | SCIE | Q4 | — | 128/139 |
| 2011 | INFECTIOUS DISEASES | SCIE | Q4 | — | 63/70 |
| 2011 | MICROBIOLOGY | SCIE | Q4 | — | 94/114 |
| 2010 | IMMUNOLOGY | SCIE | Q4 | — | 117/134 |
| 2010 | MICROBIOLOGY | SCIE | Q4 | — | 85/107 |